JOURNAL OF MEDICAL GENETICS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2192702, encodeId=430a2192e0205, content=请问投稿半个月还在 awaiting AE assignment 正常吗？可以发邮件催催嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI9B4YicCEXEBf1MdGTZslYAMrD8IfdjSg811ZvohdWtt0v9Knyg4vJibKgwRACPTxlIVpkRKiaSCNVw/132, createdBy=5f502505887, createdName=Ethel555, createdTime=Tue Mar 12 09:12:05 CST 2024, time=2024-03-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=565221, encodeId=d36d5652212f, content=问问大家，大概多久能催一下呢？已经三个月了还是Awaiting Reviewers Scores?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093632, encodeId=3e7b10936324e, content=引言一般写多少字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093631, encodeId=a430109363100, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590875, encodeId=98645908e574, content=近期投了一篇，2个月一审回来，2个审稿人，一个评价很高一个很低，主编做了拒稿决定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565220, encodeId=c22d565220a9, content=为什么我投的文章已经三个月了还是Awaiting reviewers Scores?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544242, encodeId=26ad5442429c, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530596, encodeId=6d3b5305960e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：这个刊内容涵盖人类疾病的遗传基础，包括生殖系肿瘤遗传学、遗传缺陷病临床表现、分子遗传学在临床实践中的使用、分子遗传学系统评价等内容。癌症遗传学部分是该杂志的优势。一审平均12天，投稿至接收一般3个月左右，接收后18天左右online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:38:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530595, encodeId=3bf053059559, content=一般十几天 2013-02-21 发表:: 一般awaiting reviewer scores要等多久啊？, beContent= 2013-02-21 发表:: 一般awaiting reviewer scores要等多久啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:36:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833252, encodeId=32d483325280, content=虽然排名高，但感觉不是很难，主要是即使不行，60%的文章也是1-3天就给拒信了，不耽误投别的。去年挺多篇中国文章的。据说这刊的癌症遗传学文章比较有名。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14215414107, createdName=ms7574356931796630, createdTime=Fri Aug 19 16:33:52 CST 2016, time=2016-08-19, status=1, ipAttribution=)]

2024-03-12 Ethel555 来自黑龙江省

请问投稿半个月还在 awaiting AE assignment 正常吗？可以发邮件催催嘛？

11 0

[GetPortalCommentsPageByObjectIdResponse(id=2192702, encodeId=430a2192e0205, content=请问投稿半个月还在 awaiting AE assignment 正常吗？可以发邮件催催嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI9B4YicCEXEBf1MdGTZslYAMrD8IfdjSg811ZvohdWtt0v9Knyg4vJibKgwRACPTxlIVpkRKiaSCNVw/132, createdBy=5f502505887, createdName=Ethel555, createdTime=Tue Mar 12 09:12:05 CST 2024, time=2024-03-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=565221, encodeId=d36d5652212f, content=问问大家，大概多久能催一下呢？已经三个月了还是Awaiting Reviewers Scores?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093632, encodeId=3e7b10936324e, content=引言一般写多少字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093631, encodeId=a430109363100, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590875, encodeId=98645908e574, content=近期投了一篇，2个月一审回来，2个审稿人，一个评价很高一个很低，主编做了拒稿决定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565220, encodeId=c22d565220a9, content=为什么我投的文章已经三个月了还是Awaiting reviewers Scores?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544242, encodeId=26ad5442429c, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530596, encodeId=6d3b5305960e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：这个刊内容涵盖人类疾病的遗传基础，包括生殖系肿瘤遗传学、遗传缺陷病临床表现、分子遗传学在临床实践中的使用、分子遗传学系统评价等内容。癌症遗传学部分是该杂志的优势。一审平均12天，投稿至接收一般3个月左右，接收后18天左右online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:38:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530595, encodeId=3bf053059559, content=一般十几天 2013-02-21 发表:: 一般awaiting reviewer scores要等多久啊？, beContent= 2013-02-21 发表:: 一般awaiting reviewer scores要等多久啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:36:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833252, encodeId=32d483325280, content=虽然排名高，但感觉不是很难，主要是即使不行，60%的文章也是1-3天就给拒信了，不耽误投别的。去年挺多篇中国文章的。据说这刊的癌症遗传学文章比较有名。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14215414107, createdName=ms7574356931796630, createdTime=Fri Aug 19 16:33:52 CST 2016, time=2016-08-19, status=1, ipAttribution=)]

2019-01-06 1591f99c2fm

问问大家，大概多久能催一下呢？已经三个月了还是Awaiting Reviewers Scores?

177 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192702, encodeId=430a2192e0205, content=请问投稿半个月还在 awaiting AE assignment 正常吗？可以发邮件催催嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI9B4YicCEXEBf1MdGTZslYAMrD8IfdjSg811ZvohdWtt0v9Knyg4vJibKgwRACPTxlIVpkRKiaSCNVw/132, createdBy=5f502505887, createdName=Ethel555, createdTime=Tue Mar 12 09:12:05 CST 2024, time=2024-03-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=565221, encodeId=d36d5652212f, content=问问大家，大概多久能催一下呢？已经三个月了还是Awaiting Reviewers Scores?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093632, encodeId=3e7b10936324e, content=引言一般写多少字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093631, encodeId=a430109363100, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590875, encodeId=98645908e574, content=近期投了一篇，2个月一审回来，2个审稿人，一个评价很高一个很低，主编做了拒稿决定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565220, encodeId=c22d565220a9, content=为什么我投的文章已经三个月了还是Awaiting reviewers Scores?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544242, encodeId=26ad5442429c, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530596, encodeId=6d3b5305960e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：这个刊内容涵盖人类疾病的遗传基础，包括生殖系肿瘤遗传学、遗传缺陷病临床表现、分子遗传学在临床实践中的使用、分子遗传学系统评价等内容。癌症遗传学部分是该杂志的优势。一审平均12天，投稿至接收一般3个月左右，接收后18天左右online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:38:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530595, encodeId=3bf053059559, content=一般十几天 2013-02-21 发表:: 一般awaiting reviewer scores要等多久啊？, beContent= 2013-02-21 发表:: 一般awaiting reviewer scores要等多久啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:36:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833252, encodeId=32d483325280, content=虽然排名高，但感觉不是很难，主要是即使不行，60%的文章也是1-3天就给拒信了，不耽误投别的。去年挺多篇中国文章的。据说这刊的癌症遗传学文章比较有名。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14215414107, createdName=ms7574356931796630, createdTime=Fri Aug 19 16:33:52 CST 2016, time=2016-08-19, status=1, ipAttribution=)]

2021-12-29 ms6000000264964247

引言一般写多少字？

46 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192702, encodeId=430a2192e0205, content=请问投稿半个月还在 awaiting AE assignment 正常吗？可以发邮件催催嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI9B4YicCEXEBf1MdGTZslYAMrD8IfdjSg811ZvohdWtt0v9Knyg4vJibKgwRACPTxlIVpkRKiaSCNVw/132, createdBy=5f502505887, createdName=Ethel555, createdTime=Tue Mar 12 09:12:05 CST 2024, time=2024-03-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=565221, encodeId=d36d5652212f, content=问问大家，大概多久能催一下呢？已经三个月了还是Awaiting Reviewers Scores?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093632, encodeId=3e7b10936324e, content=引言一般写多少字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093631, encodeId=a430109363100, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590875, encodeId=98645908e574, content=近期投了一篇，2个月一审回来，2个审稿人，一个评价很高一个很低，主编做了拒稿决定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565220, encodeId=c22d565220a9, content=为什么我投的文章已经三个月了还是Awaiting reviewers Scores?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544242, encodeId=26ad5442429c, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530596, encodeId=6d3b5305960e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：这个刊内容涵盖人类疾病的遗传基础，包括生殖系肿瘤遗传学、遗传缺陷病临床表现、分子遗传学在临床实践中的使用、分子遗传学系统评价等内容。癌症遗传学部分是该杂志的优势。一审平均12天，投稿至接收一般3个月左右，接收后18天左右online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:38:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530595, encodeId=3bf053059559, content=一般十几天 2013-02-21 发表:: 一般awaiting reviewer scores要等多久啊？, beContent= 2013-02-21 发表:: 一般awaiting reviewer scores要等多久啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:36:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833252, encodeId=32d483325280, content=虽然排名高，但感觉不是很难，主要是即使不行，60%的文章也是1-3天就给拒信了，不耽误投别的。去年挺多篇中国文章的。据说这刊的癌症遗传学文章比较有名。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14215414107, createdName=ms7574356931796630, createdTime=Fri Aug 19 16:33:52 CST 2016, time=2016-08-19, status=1, ipAttribution=)]

2021-12-28 Gym璨烨

引言中文章的创新性如何体现？

48 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192702, encodeId=430a2192e0205, content=请问投稿半个月还在 awaiting AE assignment 正常吗？可以发邮件催催嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI9B4YicCEXEBf1MdGTZslYAMrD8IfdjSg811ZvohdWtt0v9Knyg4vJibKgwRACPTxlIVpkRKiaSCNVw/132, createdBy=5f502505887, createdName=Ethel555, createdTime=Tue Mar 12 09:12:05 CST 2024, time=2024-03-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=565221, encodeId=d36d5652212f, content=问问大家，大概多久能催一下呢？已经三个月了还是Awaiting Reviewers Scores?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093632, encodeId=3e7b10936324e, content=引言一般写多少字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093631, encodeId=a430109363100, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590875, encodeId=98645908e574, content=近期投了一篇，2个月一审回来，2个审稿人，一个评价很高一个很低，主编做了拒稿决定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565220, encodeId=c22d565220a9, content=为什么我投的文章已经三个月了还是Awaiting reviewers Scores?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544242, encodeId=26ad5442429c, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530596, encodeId=6d3b5305960e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：这个刊内容涵盖人类疾病的遗传基础，包括生殖系肿瘤遗传学、遗传缺陷病临床表现、分子遗传学在临床实践中的使用、分子遗传学系统评价等内容。癌症遗传学部分是该杂志的优势。一审平均12天，投稿至接收一般3个月左右，接收后18天左右online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:38:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530595, encodeId=3bf053059559, content=一般十几天 2013-02-21 发表:: 一般awaiting reviewer scores要等多久啊？, beContent= 2013-02-21 发表:: 一般awaiting reviewer scores要等多久啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:36:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833252, encodeId=32d483325280, content=虽然排名高，但感觉不是很难，主要是即使不行，60%的文章也是1-3天就给拒信了，不耽误投别的。去年挺多篇中国文章的。据说这刊的癌症遗传学文章比较有名。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14215414107, createdName=ms7574356931796630, createdTime=Fri Aug 19 16:33:52 CST 2016, time=2016-08-19, status=1, ipAttribution=)]

2020-05-14 da-xiang

近期投了一篇，2个月一审回来，2个审稿人，一个评价很高一个很低，主编做了拒稿决定

123 0

[GetPortalCommentsPageByObjectIdResponse(id=2192702, encodeId=430a2192e0205, content=请问投稿半个月还在 awaiting AE assignment 正常吗？可以发邮件催催嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI9B4YicCEXEBf1MdGTZslYAMrD8IfdjSg811ZvohdWtt0v9Knyg4vJibKgwRACPTxlIVpkRKiaSCNVw/132, createdBy=5f502505887, createdName=Ethel555, createdTime=Tue Mar 12 09:12:05 CST 2024, time=2024-03-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=565221, encodeId=d36d5652212f, content=问问大家，大概多久能催一下呢？已经三个月了还是Awaiting Reviewers Scores?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093632, encodeId=3e7b10936324e, content=引言一般写多少字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093631, encodeId=a430109363100, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590875, encodeId=98645908e574, content=近期投了一篇，2个月一审回来，2个审稿人，一个评价很高一个很低，主编做了拒稿决定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565220, encodeId=c22d565220a9, content=为什么我投的文章已经三个月了还是Awaiting reviewers Scores?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544242, encodeId=26ad5442429c, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530596, encodeId=6d3b5305960e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：这个刊内容涵盖人类疾病的遗传基础，包括生殖系肿瘤遗传学、遗传缺陷病临床表现、分子遗传学在临床实践中的使用、分子遗传学系统评价等内容。癌症遗传学部分是该杂志的优势。一审平均12天，投稿至接收一般3个月左右，接收后18天左右online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:38:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530595, encodeId=3bf053059559, content=一般十几天 2013-02-21 发表:: 一般awaiting reviewer scores要等多久啊？, beContent= 2013-02-21 发表:: 一般awaiting reviewer scores要等多久啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:36:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833252, encodeId=32d483325280, content=虽然排名高，但感觉不是很难，主要是即使不行，60%的文章也是1-3天就给拒信了，不耽误投别的。去年挺多篇中国文章的。据说这刊的癌症遗传学文章比较有名。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14215414107, createdName=ms7574356931796630, createdTime=Fri Aug 19 16:33:52 CST 2016, time=2016-08-19, status=1, ipAttribution=)]

2019-01-06 1591f99c2fm

为什么我投的文章已经三个月了还是Awaiting reviewers Scores?

209 0

[GetPortalCommentsPageByObjectIdResponse(id=2192702, encodeId=430a2192e0205, content=请问投稿半个月还在 awaiting AE assignment 正常吗？可以发邮件催催嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI9B4YicCEXEBf1MdGTZslYAMrD8IfdjSg811ZvohdWtt0v9Knyg4vJibKgwRACPTxlIVpkRKiaSCNVw/132, createdBy=5f502505887, createdName=Ethel555, createdTime=Tue Mar 12 09:12:05 CST 2024, time=2024-03-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=565221, encodeId=d36d5652212f, content=问问大家，大概多久能催一下呢？已经三个月了还是Awaiting Reviewers Scores?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093632, encodeId=3e7b10936324e, content=引言一般写多少字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093631, encodeId=a430109363100, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590875, encodeId=98645908e574, content=近期投了一篇，2个月一审回来，2个审稿人，一个评价很高一个很低，主编做了拒稿决定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565220, encodeId=c22d565220a9, content=为什么我投的文章已经三个月了还是Awaiting reviewers Scores?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544242, encodeId=26ad5442429c, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530596, encodeId=6d3b5305960e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：这个刊内容涵盖人类疾病的遗传基础，包括生殖系肿瘤遗传学、遗传缺陷病临床表现、分子遗传学在临床实践中的使用、分子遗传学系统评价等内容。癌症遗传学部分是该杂志的优势。一审平均12天，投稿至接收一般3个月左右，接收后18天左右online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:38:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530595, encodeId=3bf053059559, content=一般十几天 2013-02-21 发表:: 一般awaiting reviewer scores要等多久啊？, beContent= 2013-02-21 发表:: 一般awaiting reviewer scores要等多久啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:36:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833252, encodeId=32d483325280, content=虽然排名高，但感觉不是很难，主要是即使不行，60%的文章也是1-3天就给拒信了，不耽误投别的。去年挺多篇中国文章的。据说这刊的癌症遗传学文章比较有名。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14215414107, createdName=ms7574356931796630, createdTime=Fri Aug 19 16:33:52 CST 2016, time=2016-08-19, status=1, ipAttribution=)]

2017-07-16 zheyang

还是5分多,虽然没有大变化,能稳定在些,也算是中上等

348 0

[GetPortalCommentsPageByObjectIdResponse(id=2192702, encodeId=430a2192e0205, content=请问投稿半个月还在 awaiting AE assignment 正常吗？可以发邮件催催嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI9B4YicCEXEBf1MdGTZslYAMrD8IfdjSg811ZvohdWtt0v9Knyg4vJibKgwRACPTxlIVpkRKiaSCNVw/132, createdBy=5f502505887, createdName=Ethel555, createdTime=Tue Mar 12 09:12:05 CST 2024, time=2024-03-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=565221, encodeId=d36d5652212f, content=问问大家，大概多久能催一下呢？已经三个月了还是Awaiting Reviewers Scores?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093632, encodeId=3e7b10936324e, content=引言一般写多少字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093631, encodeId=a430109363100, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590875, encodeId=98645908e574, content=近期投了一篇，2个月一审回来，2个审稿人，一个评价很高一个很低，主编做了拒稿决定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565220, encodeId=c22d565220a9, content=为什么我投的文章已经三个月了还是Awaiting reviewers Scores?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544242, encodeId=26ad5442429c, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530596, encodeId=6d3b5305960e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：这个刊内容涵盖人类疾病的遗传基础，包括生殖系肿瘤遗传学、遗传缺陷病临床表现、分子遗传学在临床实践中的使用、分子遗传学系统评价等内容。癌症遗传学部分是该杂志的优势。一审平均12天，投稿至接收一般3个月左右，接收后18天左右online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:38:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530595, encodeId=3bf053059559, content=一般十几天 2013-02-21 发表:: 一般awaiting reviewer scores要等多久啊？, beContent= 2013-02-21 发表:: 一般awaiting reviewer scores要等多久啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:36:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833252, encodeId=32d483325280, content=虽然排名高，但感觉不是很难，主要是即使不行，60%的文章也是1-3天就给拒信了，不耽误投别的。去年挺多篇中国文章的。据说这刊的癌症遗传学文章比较有名。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14215414107, createdName=ms7574356931796630, createdTime=Fri Aug 19 16:33:52 CST 2016, time=2016-08-19, status=1, ipAttribution=)]

2016-12-14 HawkingS2832

审稿速度:1.0 | 投稿命中率:25.0
经验分享：这个刊内容涵盖人类疾病的遗传基础，包括生殖系肿瘤遗传学、遗传缺陷病临床表现、分子遗传学在临床实践中的使用、分子遗传学系统评价等内容。癌症遗传学部分是该杂志的优势。一审平均12天，投稿至接收一般3个月左右，接收后18天左右online。

386 0

[GetPortalCommentsPageByObjectIdResponse(id=2192702, encodeId=430a2192e0205, content=请问投稿半个月还在 awaiting AE assignment 正常吗？可以发邮件催催嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI9B4YicCEXEBf1MdGTZslYAMrD8IfdjSg811ZvohdWtt0v9Knyg4vJibKgwRACPTxlIVpkRKiaSCNVw/132, createdBy=5f502505887, createdName=Ethel555, createdTime=Tue Mar 12 09:12:05 CST 2024, time=2024-03-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=565221, encodeId=d36d5652212f, content=问问大家，大概多久能催一下呢？已经三个月了还是Awaiting Reviewers Scores?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093632, encodeId=3e7b10936324e, content=引言一般写多少字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093631, encodeId=a430109363100, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590875, encodeId=98645908e574, content=近期投了一篇，2个月一审回来，2个审稿人，一个评价很高一个很低，主编做了拒稿决定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565220, encodeId=c22d565220a9, content=为什么我投的文章已经三个月了还是Awaiting reviewers Scores?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544242, encodeId=26ad5442429c, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530596, encodeId=6d3b5305960e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：这个刊内容涵盖人类疾病的遗传基础，包括生殖系肿瘤遗传学、遗传缺陷病临床表现、分子遗传学在临床实践中的使用、分子遗传学系统评价等内容。癌症遗传学部分是该杂志的优势。一审平均12天，投稿至接收一般3个月左右，接收后18天左右online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:38:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530595, encodeId=3bf053059559, content=一般十几天 2013-02-21 发表:: 一般awaiting reviewer scores要等多久啊？, beContent= 2013-02-21 发表:: 一般awaiting reviewer scores要等多久啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:36:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833252, encodeId=32d483325280, content=虽然排名高，但感觉不是很难，主要是即使不行，60%的文章也是1-3天就给拒信了，不耽误投别的。去年挺多篇中国文章的。据说这刊的癌症遗传学文章比较有名。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14215414107, createdName=ms7574356931796630, createdTime=Fri Aug 19 16:33:52 CST 2016, time=2016-08-19, status=1, ipAttribution=)]

2016-12-14 HawkingS2832

一般十几天 2013-02-21 发表::
一般awaiting reviewer scores要等多久啊？

2013-02-21 发表:: 一般awaiting reviewer scores要等多久啊？

355 0

[GetPortalCommentsPageByObjectIdResponse(id=2192702, encodeId=430a2192e0205, content=请问投稿半个月还在 awaiting AE assignment 正常吗？可以发邮件催催嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI9B4YicCEXEBf1MdGTZslYAMrD8IfdjSg811ZvohdWtt0v9Knyg4vJibKgwRACPTxlIVpkRKiaSCNVw/132, createdBy=5f502505887, createdName=Ethel555, createdTime=Tue Mar 12 09:12:05 CST 2024, time=2024-03-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=565221, encodeId=d36d5652212f, content=问问大家，大概多久能催一下呢？已经三个月了还是Awaiting Reviewers Scores?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093632, encodeId=3e7b10936324e, content=引言一般写多少字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093631, encodeId=a430109363100, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590875, encodeId=98645908e574, content=近期投了一篇，2个月一审回来，2个审稿人，一个评价很高一个很低，主编做了拒稿决定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565220, encodeId=c22d565220a9, content=为什么我投的文章已经三个月了还是Awaiting reviewers Scores?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jan 06 00:00:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544242, encodeId=26ad5442429c, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530596, encodeId=6d3b5305960e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：这个刊内容涵盖人类疾病的遗传基础，包括生殖系肿瘤遗传学、遗传缺陷病临床表现、分子遗传学在临床实践中的使用、分子遗传学系统评价等内容。癌症遗传学部分是该杂志的优势。一审平均12天，投稿至接收一般3个月左右，接收后18天左右online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:38:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530595, encodeId=3bf053059559, content=一般十几天 2013-02-21 发表:: 一般awaiting reviewer scores要等多久啊？, beContent= 2013-02-21 发表:: 一般awaiting reviewer scores要等多久啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:36:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833252, encodeId=32d483325280, content=虽然排名高，但感觉不是很难，主要是即使不行，60%的文章也是1-3天就给拒信了，不耽误投别的。去年挺多篇中国文章的。据说这刊的癌症遗传学文章比较有名。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14215414107, createdName=ms7574356931796630, createdTime=Fri Aug 19 16:33:52 CST 2016, time=2016-08-19, status=1, ipAttribution=)]

2016-08-19 ms7574356931796630

虽然排名高，但感觉不是很难，主要是即使不行，60%的文章也是1-3天就给拒信了，不耽误投别的。去年挺多篇中国文章的。据说这刊的癌症遗传学文章比较有名。

127 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务